Across TCGA pan-cancer cohorts, ZDHHC24 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZDHHC24 data layer compared with 26 for mass-spec protein and 4 for mass-spec protein.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher ZDHHC24 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZDHHC24 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.
COAD, UCEC, and SKCM are the cancer types where ZDHHC24 Mutation most reproducibly stratifies survival.